119 related articles for article (PubMed ID: 33865271)
21. MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway.
Jia F; Zhang Z; Zhang X
J Cell Biochem; 2019 Apr; 120(4):6420-6430. PubMed ID: 30484892
[TBL] [Abstract][Full Text] [Related]
22. microRNA-377-3p inhibits osteosarcoma progression by targeting CUL1 and regulating Wnt/β-catenin signaling pathway.
Liang K; Liao L; Liu Q; Ouyang Q; Jia L; Wu G
Clin Transl Oncol; 2021 Nov; 23(11):2350-2357. PubMed ID: 34133001
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic and prognostic implications of serum miR-101 in osteosarcoma.
Yao ZS; Li C; Liang D; Jiang XB; Tang JJ; Ye LQ; Yuan K; Ren H; Yang ZD; Jin DX; Zhang SC; Ding JY; Tang YC; Xu JX; Chen K; Xie WX; Guo DQ; Cui JC
Cancer Biomark; 2018; 22(1):127-133. PubMed ID: 29630525
[TBL] [Abstract][Full Text] [Related]
24. LINC00319 promotes osteosarcoma progression by regulating the miR-455-3p/NFIB axis.
Sun F; Yu Z; Wu B; Zhang H; Ruan J
J Gene Med; 2020 Nov; 22(11):e3248. PubMed ID: 32621625
[TBL] [Abstract][Full Text] [Related]
25. Long Noncoding MT1JP Enhanced the Inhibitory Effects of miR-646 on FGF2 in Osteosarcoma.
Yang L; Liu G; Xiao S; Wang L; Liu X; Tan Q; Li Z
Cancer Biother Radiopharm; 2020 Jun; 35(5):371-376. PubMed ID: 32196384
[No Abstract] [Full Text] [Related]
26. Circ_0081001 down-regulates miR-494-3p to enhance BACH1 expression and promotes osteosarcoma progression.
Liu S; Duan K; Zhang X; Cao X; Wang X; Meng F; Liu H; Xu B; Wang X
Aging (Albany NY); 2021 Jun; 13(13):17274-17284. PubMed ID: 34191748
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.
Fujiwara T; Uotani K; Yoshida A; Morita T; Nezu Y; Kobayashi E; Yoshida A; Uehara T; Omori T; Sugiu K; Komatsubara T; Takeda K; Kunisada T; Kawamura M; Kawai A; Ochiya T; Ozaki T
Oncotarget; 2017 May; 8(20):33375-33392. PubMed ID: 28380419
[TBL] [Abstract][Full Text] [Related]
28. miR-1285-3p is a potential prognostic marker in human osteosarcoma and functions as a tumor suppressor by targeting YAP1.
Hu XH; Dai J; Shang HL; Zhao ZX; Hao YD
Cancer Biomark; 2019; 25(1):1-10. PubMed ID: 31006663
[TBL] [Abstract][Full Text] [Related]
29. Circ-0003998 promotes cell proliferative ability and invasiveness by binding to miR-197-3p in osteosarcoma.
Wang L; Du ZG; Huang H; Li FS; Li GS; Xu SN
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10638-10646. PubMed ID: 31858530
[TBL] [Abstract][Full Text] [Related]
30. miR-143-3p inhibits the proliferation, migration and invasion in osteosarcoma by targeting FOSL2.
Sun X; Dai G; Yu L; Hu Q; Chen J; Guo W
Sci Rep; 2018 Jan; 8(1):606. PubMed ID: 29330462
[TBL] [Abstract][Full Text] [Related]
31. Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis.
Xue WX; Zhang MY; Rui Li ; Liu X; Yin YH; Qu YQ
Biomed Res Int; 2020; 2020():9601876. PubMed ID: 32724822
[TBL] [Abstract][Full Text] [Related]
32. MiR-501-3p promotes osteosarcoma cell proliferation, migration and invasion by targeting BCL7A.
Dai J; Lu L; Kang L; Zhang J
Hum Cell; 2021 Mar; 34(2):624-633. PubMed ID: 33415690
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of hsa_circ_0136666 predicts poor prognosis and initiates osteosarcoma tumorigenesis through miR-593-3p/ZEB2 pathway.
Zhang C; Zhou H; Yuan K; Xie R; Chen C
Aging (Albany NY); 2020 May; 12(11):10488-10496. PubMed ID: 32424109
[TBL] [Abstract][Full Text] [Related]
34. Loss of MicroRNA-489-3p promotes osteosarcoma metastasis by activating PAX3-MET pathway.
Liu Q; Yang G; Qian Y
Mol Carcinog; 2017 Apr; 56(4):1312-1321. PubMed ID: 27859625
[TBL] [Abstract][Full Text] [Related]
35. Identification of plasma microRNA-22 as a marker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma.
Diao ZB; Sun TX; Zong Y; Lin BC; Xia YS
J Int Med Res; 2020 Dec; 48(12):300060520967818. PubMed ID: 33284712
[TBL] [Abstract][Full Text] [Related]
36. LncRNA ODRUL regulates progression of osteosarcoma by regulating IL-6 via sponging miR-6874-3p.
Zhan T; Zhu K; Hu J; Ma X; Zhu Y; Zhang C
Exp Cell Res; 2022 Mar; 412(2):113050. PubMed ID: 35114192
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of the microRNA-29 family in patients with primary osteosarcomas.
Hong Q; Fang J; Pang Y; Zheng J
Med Oncol; 2014 Aug; 31(8):37. PubMed ID: 25015394
[TBL] [Abstract][Full Text] [Related]
38. miR-497 as a potential serum biomarker for the diagnosis and prognosis of osteosarcoma.
Pang PC; Shi XY; Huang WL; Sun K
Eur Rev Med Pharmacol Sci; 2016 Sep; 20(18):3765-3769. PubMed ID: 27735043
[TBL] [Abstract][Full Text] [Related]
39. LncRNA PCAT-1 promotes the progression of osteosarcoma via miR-508-3p/ZEB1 axis.
Chang L; Jia DL; Cao CS; Wei H; Li ZQ
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2517-2527. PubMed ID: 33829438
[TBL] [Abstract][Full Text] [Related]
40. Clinical and Molecular Analysis of Pathologic Fracture-associated Osteosarcoma: MicroRNA profile Is Different and Correlates with Prognosis.
Lozano Calderón SA; Garbutt C; Kim J; Lietz CE; Chen YL; Bernstein K; Chebib I; Nielsen GP; Deshpande V; Rubio R; Wang YE; Quackenbush J; Delaney T; Raskin K; Schwab J; Cote G; Spentzos D
Clin Orthop Relat Res; 2019 Sep; 477(9):2114-2126. PubMed ID: 31389890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]